An aptamer-regulated CRISPR/Cas12a system based on split crRNA for theophylline and tobramycin detection
Analytical Methods · 2026
DOI: 10.1039/d6ay01469k ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Methods, 2026. Verfasst von Jinming Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, China. zhkhe@whu.edu.cn. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Tobramycin, Theophylline, CRISPR-Cas Systems. Die Arbeit nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
An aptamer-regulated CRISPR/Cas12a system based on split crRNA was developed for theophylline and tobramycin detection through target‑induced signal reduction and lateral flow visual readout.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, China. zhkhe@whu.edu.cn.
- Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Province Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, J., Li, L., Tang, Z., Li, Y., Zhou, F., He, Z., & Ji, X. (2026). An aptamer-regulated CRISPR/Cas12a system based on split crRNA for theophylline and tobramycin detection. Analytical Methods. https://doi.org/10.1039/d6ay01469k
Vancouver
Liu J, Li L, Tang Z, Li Y, Zhou F, He Z, et al. An aptamer-regulated CRISPR/Cas12a system based on split crRNA for theophylline and tobramycin detection. Analytical Methods. 2026. doi:10.1039/d6ay01469k
BibTeX
@article{Liu2026,
author = {Liu, Jinming and Li, Le and Tang, Ziwen and Li, Yachen and Zhou, Fuxiang and He, Zhike and Ji, Xinghu},
title = {An aptamer-regulated CRISPR/Cas12a system based on split crRNA for theophylline and tobramycin detection},
journal = {Analytical Methods},
year = {2026},
doi = {10.1039/d6ay01469k}
}
EUVIMED